Work

Use and clinical outcomes of androgen receptor inhibitors (ARIs) for non-metastatic castration resistant prostate cancer (nmCRPC) at labeled doses in Japan.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.5_suppl.170

Authors: Kazuhiro Suzuki, Nasreen Khan, Tomoyuki Taguchi, Kana Hattori, Guifang Chen, Mercedeh Ghadessi, Niculae Constantinovici, Vanessa Quintero, Hiroyoshi Suzuki

Institutions: Gunma University, Bayer (United States), Bayer (Japan), Bayer (Switzerland), Toho University, Toho University Medical Center Sakura Hospital

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Bayer

OpenAlex ID: W4407702770

Cites:

Cited by:

Related to: 10